Concepedia
Statistics
Publications
13
Citations
488
H-Index
12
Active since
2010
Affiliations
Beth Israel Deaconess Medical Center(Current)
Harvard University
University of North Carolina at Chapel Hill
Cancer Research Institute
Finith E. Jernigan is an author at Beth Israel Deaconess Medical Center specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesBiophysicsCell BiologyMedicinal ChemistryImmunologyEngineering
Publications per year
2010–2022
Synthesis and anticancer activity of novel water soluble benzimidazole carbamates
Jae Eun Cheong, Michela Zaffagni, Ivy Chung et al. · European Journal of Medicinal Chemistry · 2017 · 113 citations
Medicinal Chemistry, Biochemistry, Medicine +7
Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase
Steffi Koerner, Jun‐ichi Hanai, Sha Bai et al. · European Journal of Medicinal Chemistry · 2016 · 84 citations · Full text
Medicinal Chemistry, Biosynthesis, Biochemistry +12
Suborganelle Sensing of Mitochondrial cAMP-Dependent Protein Kinase Activity
Richard S. Agnes, Finith E. Jernigan, Jennifer R. Shell et al. · Journal of the American Chemical Society · 2010 · 71 citations
Suborganelle Sensing, Cytoskeleton, Cellular Physiology +16
Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists
Jiaxuan Chen, Carolyn A. Haller, Finith E. Jernigan et al. · Science Advances · 2020 · 54 citations · Full text
Chronic Inflammatory Diseases, Immunology, Innate Immunity +19
Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation
Yiqiang Wang, Andreas Hedblom, Steffi Koerner et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 29 citations · Full text
Oncogenic Agent, Medicine, Kras Mutation +8
1–5 of 13